Designing a binder is an easier process than designing a drug, but it’s a useful proxy. The typical success rate in the field today is betwe
Designing a binder is an easier process than designing a drug, but it’s a useful proxy. The typical success rate in the field today is between 10% and 15%. Between 22% and 35% of Claude's designs bound successfully, depending on the setup. Some of its strongest designs bound https://t.co/nIVU00ZgiH
Why this byte is shareable
Signal quality
official
Confidence badge and source context included.
Entity anchor
Anthropic
Clear company or model context for distribution.
Export ready
1200 x 630 card
Optimized for X, LinkedIn, and chat previews.
Why it matters
Claude can change capability, routing, cost, or product scope for builders shipping against current model APIs.
Suggested launch post
Use this in X threads, community posts, internal team chats, or launch recaps.
Designing a binder is an easier process than designing a drug, but it’s a useful proxy. The typical success rate in the field today is betwe Why it matters: Claude can change capability, routing, cost, or product scope for builders shipping against current model APIs. Source...
Permalink: https://a2zai.ai/bytes/designing-a-binder-is-an-easier-process-than-designing-a-drug-but-it-s-a-useful--8e5e933f
Social card: https://a2zai.ai/bytes/designing-a-binder-is-an-easier-process-than-designing-a-drug-but-it-s-a-useful--8e5e933f/opengraph-image